Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.

Literature DB >> 17947275

Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.

Carsten Heinz, Hartmut Merz, Matthias Nieschalk, Heribert Mueller-Miny, Peter Koch, Arnd Heiligenhaus.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2007 PMID： 17947275 PMCID： PMC2095418 DOI： 10.1136/bjo.2007.115626

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

× No keyword cloud information.

5 in total

1. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors: Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal: Virchows Arch Date: 2005-12-02 Impact factor: 4.064

2. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland--a case report.

Authors: Ioannis Asproudis; Spiridon Gorezis; Georgios C Charonis; Christos Tolis; Elena Tsanou; Tsanou Elena; Niki J Agnantis
Journal: In Vivo Date: 2005 Nov-Dec Impact factor: 2.155

3. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa.

Authors: Andrés J M Ferreri; Maurilio Ponzoni; Giovanni Martinelli; Giuliana Muti; Massimo Guidoboni; Riccardo Dolcetti; Claudio Doglioni
Journal: Haematologica Date: 2005-11 Impact factor: 9.941

4. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.

Authors: J Pijpe; G W van Imhoff; A Vissink; J E van der Wal; P M Kluin; F K L Spijkervet; C G M Kallenberg; H Bootsma
Journal: Ann Rheum Dis Date: 2004-12-02 Impact factor: 19.103

5. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.

Authors: Holger Nückel; Daniel Meller; Klaus-Peter Steuhl; Ulrich Dührsen
Journal: Eur J Haematol Date: 2004-10 Impact factor: 2.997

5 in total

8 in total

Review 1. Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors: Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal: Clin Exp Med Date: 2017-09-22 Impact factor: 3.984

Review 2. [Lymphoma of the ocular adnexa].

Authors: V Kakkassery; N Stübiger; I A Adamietz; I Tischoff; A Baraniskin; I M Wunderlich
Journal: Ophthalmologe Date: 2015-03 Impact factor: 1.059

Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.

1. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

2. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland--a case report.

3. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa.

4. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.

5. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.

Review 1. Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Review 2. [Lymphoma of the ocular adnexa].

Review 3. Extranodal marginal zone lymphoma of the ocular adnexa.

4. Extra-Nodal Marginal Zone Lymphoma (MZL) of MALT CD20+ of the Ocular Adnexa: Case Report.

5. Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

Review 6. Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy.

Review 7. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.

8. Ocular adnexal lymphoma: A single-institution retrospective study.